Stopping Cervical Cancer Before It Starts

A researcher focused on developing therapeutic vaccines for the human papillomavirus (HPV), Alton Gayton will graduate from the Harvard Kenneth C. Griffin Graduate School of Arts and Sciences in May 2026 with a PhD in virology. He discusses his pioneering work using circular RNA and artificial intelligence to treat and prevent cervical cancer, his upbringing in North Carolina, and his path from there to Harvard, via the University of North Carolina. Read the full article on the Harvard Griffin Graduate School of Arts and Sciences site.